In 2006 was created Apposite Capital, which is appeared as VC. The fund was located in Europe if to be more exact in United Kingdom. The leading representative office of defined VC is situated in the London.
The higher amount of exits for fund were in 2015. The common things for fund are deals in the range of 10 - 50 millions dollars. The real fund results show that this VC is 27 percentage points more often commits exit comparing to other companies. The important activity for fund was in 2009. Despite it in 2019 the fund had an activity. This Apposite Capital works on 0 percentage points more the average amount of lead investments comparing to the other organizations. The fund is constantly included in less than 2 deals per year.
The fund has exact preference in a number of founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. Among the various public portfolio startups of the fund, we may underline Anaphore, Bird Rock Bio, Ambrx Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular fund investment industries, there are Life Science, Health Care.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Apposite Capital, startups are often financed by 5AM Ventures, Versant Ventures, Tavistock Life Sciences. The meaningful sponsors for the fund in investment in the same round are Versant Ventures, 5AM Ventures, Roche Venture Fund. In the next rounds fund is usually obtained by M Ventures, Versant Ventures, SR One.
Besides them, we counted 4 critical employees of this fund in our database.
Related Funds
Funds with similar focus
Fund Name | Location |
365.fintech | District of Zvolen, Region of Banská Bystrica, Slovakia |
Harvard Angel Group | Boston, Massachusetts, United States |
IFG Healthcare | Cincinnati, Ohio, United States |
Invivo Capital Partners | Barcelona, Catalonia, Spain |
Panoramic Ventures | Atlanta, Georgia, United States |
ProQuest Investments | New Jersey, Princeton, United States |
SHINMEI | Japan, Tokyo |
Stableton Financial | Switzerland, Zug, Zug |
The Longevity Fund | California, San Francisco, United States |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Bird Rock Bio | $15M | 27 Mar 2014 | San Diego, California, United States | ||
Ulthera | $10M | 08 Feb 2011 | Mesa, Arizona, United States | ||
Convergence Pharmaceuticals | $35M | 05 Oct 2010 | England | ||
$13M | 09 Jun 2009 | San Diego, California, United States | |||
Bird Rock Bio | $25M | 07 Jan 2009 | San Diego, California, United States | ||
Serentis | $7M | 12 Aug 2008 | Cambridge, England, United Kingdom | ||
Serentis | $20M | 27 Jun 2007 | United Kingdom, England | ||
PharmaKodex | $9M | 21 Nov 2006 | Cambridge, Massachusetts, United States | ||
Ambrx | $52M | 05 Jul 2006 | San Diego, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Bird Rock Bio | $15M | 27 Mar 2014 | San Diego, California, United States | ||
Ulthera | $10M | 08 Feb 2011 | Mesa, Arizona, United States | ||
Convergence Pharmaceuticals | $35M | 05 Oct 2010 | England | ||
$13M | 09 Jun 2009 | San Diego, California, United States | |||
Bird Rock Bio | $25M | 07 Jan 2009 | San Diego, California, United States | ||
Serentis | $7M | 12 Aug 2008 | Cambridge, England, United Kingdom | ||
Serentis | $20M | 27 Jun 2007 | United Kingdom, England | ||
PharmaKodex | $9M | 21 Nov 2006 | Cambridge, Massachusetts, United States | ||
Ambrx | $52M | 05 Jul 2006 | San Diego, California, United States |